Amount Raised
$112 Million
Round Type
Series B
WatertownBiotechnologyHealth CareTherapeuticsBiotechnology ResearchDescription
Neumora Therapeutics, Inc. (Neumora), a clinical-stage biotechnology company pioneering precision medicines for brain diseases through the integration of data science and neuroscience, today announced the close of a $112 million Series B financing. The Series B syndicate includes both new and existing investors, such as Abu Dhabi Growth Fund (ADG), Altitude Life Science Ventures, Amgen, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Mubadala Capital, Newpath Partners, Polaris Partners and other undisclosed investors. The funding will support the advancement of a broad clinical and preclinical pipeline of novel precision medicine candidates for neuropsychiatric disorders and neurodegenerative diseases and the development of the company's precision neuroscience platform.
Quick answer
Neumora raised $112 Million in a Series B round, dated October 11, 2022. Neumora is based in Watertown, Massachusetts, United States.
- How much did Neumora raise?
- Neumora raised $112 Million in a Series B round on October 11, 2022.
- What does Neumora do?
- Brain diseases collectively represent one of the greatest challenges of our generation, affecting upwards of 1.5 billion people.
- Where is Neumora based and how big is it?
- Neumora is based in Watertown, Massachusetts, United States.
- Who are the decision-makers at Neumora?
- Fundz holds 1 contact at Neumora. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology Research around the same time
Companies in the same sectors as Neumora that raised within 45 days of this round, from Fundz verified event records.
- Opna Bio raised $38M (Series A) on November 21, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
- Arialys Therapeutics raised $14M on November 18, 2022.
- Parabilis Medicines raised $178M on November 17, 2022.
- Cue Biopharma raised an undisclosed amount (Funding Round) on November 17, 2022.
- Cue Biopharma raised $30M on November 16, 2022.
Who to call at Neumora, and when
A new round usually means Neumora is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neumora raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neumora, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neumora. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neumora raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansNeumora raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.